Chemical formula of Lumefantrine
0

Lumefantrine - Coartem - Riamet Analysis

€149.00
Tax included
LUMEFANTRINE

Laboratory analysis of drugs to certify the presence of Lumefantrine and measure the amount of Lumefantrine.

The level of uncertainty of the Lumefantrine content analysis depends on the declination selected (Standard <20%, Precise <10% or Regulatory <5%).

Follow the instructions to send your drug to our laboratory for analysis.

Results within 15 working days of receipt of sample.

Analysis: Standard

Lumefantrine is a drug used in the treatment of malaria, caused by infection with the parasite Plasmodium falciparum. Lumefantrine is included in the World Health Organization's (WHO) list of essential medicines.

Lumefantrine is the active ingredient in Coartem (in combination with artemether), marketed by the Novartis laboratory.

Consuming medicines ordered from dubious or illegal sites presents a health risk. It is essential to check that the online pharmacy is reputable and fully authorized.

If you have any doubts about the origin of the drug, you should carry out an analysis to certify the presence of the active ingredient and check that its dosage in the drug complies with the indicated content.

Analysis

Lumefantrine is analyzed by liquid chromatography coupled with UV-Visible spectrophotometric detection (HPLC-UV Visible).

Chemical name

  • Chemical name: (2R)-2-(dibutylamino)-1-[2,7-dichloro-9-(4-chlorobenzylidene)-9H-fluoren-4-yl]ethan-1-one
  • Chemical formula: C30H32Cl3NO
  • CAS number: 82186-77-4

Therapeutic class

  • Therapeutic class: antimalarial (combined with artemether for artemisinin-based combination therapy)

Description of Therapeutic Effects

Lumefantrine is an antimalarial agent used in the treatment of uncomplicated infections caused by Plasmodium falciparum. It is always administered in combination with artemether to avoid the development of resistance.

Mechanism of action :

  • Lumefantrine interferes with the detoxification of heme (a toxic by-product of the parasite's digestion of hemoglobin).
  • It acts primarily by destroying the bloodstream forms of the parasite responsible for the disease.

Main effects :

  • Eliminates parasites from the bloodstream.
  • Rapid reduction in malaria symptoms such as fever and headaches.

Trade names

  • Coartem (artemether-lumefantrine combination)
  • Riamet (commercial name in Europe)
  • Generics available in some regions under various names.

Main Manufacturers

  • Novartis: Main manufacturer of Coartem.
  • Cipla: Supplier of generic formulations.
  • Ipca Laboratories: Producer for emerging markets.
  • Sanofi: Supplier in certain regions.
  • Mylan: Manufacturer of generic versions for specific markets.
LUMEFANTRINE

Specific References

Your drug is analyzed by our expert pharmaceutical analysis laboratory.

The drug to be analyzed must be sent in at least 3 copies in its original packaging (box or vial + blister pack) in order to have all the information.

The drug to be analyzed must be sufficiently protected to avoid any deterioration or damage during transport.

The drug to be analyzed must be accompanied by the completed analysis form.

Documents to download:

The use of counterfeit or illegal medicines (without patent authorisation) presents a proven risk to patients' health:

  • Absence of the active ingredient
  • Under-dosage of the active ingredient
  • Over-dosage of the active ingredient
  • Toxic synthetic or degradation impurities
  • Presence of another active ingredient
  • Toxic excipients
  • Presence of toxic residual solvents
  • ...

The trade in counterfeit medicines is flourishing and growing exponentially with online trading. The authorities believe that more than half of all medicines sold over the Internet are counterfeit or illegal.

Comments (0)

Lumefantrine - Coartem -...

€149.00